| scholarly article | Q13442814 |
| P2093 | author name string | Jiaoti Huang | |
| Daniel J Margolis | |||
| Frederick J Dorey | |||
| Leonard S Marks | |||
| Shyam Natarajan | |||
| Nima Nassiri | |||
| Devi S Sharma | |||
| P2860 | cites work | Multiparametric Magnetic Resonance Imaging (MRI) and MRI-Transrectal Ultrasound Fusion Biopsy for Index Tumor Detection: Correlation with Radical Prostatectomy Specimen | Q40062114 |
| Medium-term outcomes of active surveillance for localised prostate cancer. | Q40096721 | ||
| Metastatic Prostate Cancer in Men Initially Treated with Active Surveillance | Q41018996 | ||
| Initial experience with electronic tracking of specific tumor sites in men undergoing active surveillance of prostate cancer | Q42551257 | ||
| Expanded criteria to identify men eligible for active surveillance of low risk prostate cancer at Johns Hopkins: a preliminary analysis | Q43766423 | ||
| Tumor target volume for focal therapy of prostate cancer-does multiparametric magnetic resonance imaging allow for a reliable estimation? | Q43869254 | ||
| A new risk classification system for therapeutic decision making with intermediate-risk prostate cancer patients undergoing dose-escalated external-beam radiation therapy. | Q45904187 | ||
| Extended followup and risk factors for disease reclassification in a large active surveillance cohort for localized prostate cancer | Q46258204 | ||
| Histologic differentiation, cancer volume, and pelvic lymph node metastasis in adenocarcinoma of the prostate | Q46616466 | ||
| Prostate Cancer, Version 1.2016. | Q46889765 | ||
| Biological determinants of cancer progression in men with prostate cancer | Q51090543 | ||
| Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. | Q55067996 | ||
| Long-Term Follow-Up of a Large Active Surveillance Cohort of Patients With Prostate Cancer | Q57696209 | ||
| Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer | Q71606146 | ||
| Clinical application of a 3D ultrasound-guided prostate biopsy system | Q24608010 | ||
| Active surveillance for prostate cancer: current evidence and contemporary state of practice | Q28066534 | ||
| PI-RADS Prostate Imaging – Reporting and Data System: 2015, Version 2 | Q29037908 | ||
| Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer. | Q30664726 | ||
| Targeted prostate biopsy in select men for active surveillance: do the Epstein criteria still apply? | Q34032598 | ||
| Magnetic resonance imaging-ultrasound fusion biopsy for prediction of final prostate pathology | Q34364108 | ||
| Gleason score 6 adenocarcinoma: should it be labeled as cancer? | Q36449197 | ||
| Targeted biopsy in the detection of prostate cancer using an office based magnetic resonance ultrasound fusion device | Q36579232 | ||
| Prostate cancer detection with magnetic resonance-ultrasound fusion biopsy: The role of systematic and targeted biopsies | Q36649765 | ||
| Intermediate and Longer-Term Outcomes From a Prospective Active-Surveillance Program for Favorable-Risk Prostate Cancer | Q36892392 | ||
| Value of targeted prostate biopsy using magnetic resonance-ultrasound fusion in men with prior negative biopsy and elevated prostate-specific antigen | Q37381526 | ||
| Do adenocarcinomas of the prostate with Gleason score (GS) ≤6 have the potential to metastasize to lymph nodes? | Q38005257 | ||
| Use of mpMRI in active surveillance for localized prostate cancer | Q38795731 | ||
| P433 | issue | 3 Pt 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 632-639 | |
| P577 | publication date | 2016-09-14 | |
| P1433 | published in | Journal of Urology | Q15709979 |
| P1476 | title | Targeted Biopsy to Detect Gleason Score Upgrading during Active Surveillance for Men with Low versus Intermediate Risk Prostate Cancer | |
| P478 | volume | 197 |
| Q47904164 | Active surveillance of prostate cancer: Current state of practice and utility of multiparametric magnetic resonance imaging. |
| Q47662268 | In-bore MRI-guided biopsy: can it optimize the need for periodic biopsies in prostate cancer patients undergoing active surveillance? a pilot test-retest reliability study |
| Q88352410 | Integration and Diagnostic Accuracy of 3T Nonendorectal coil Prostate Magnetic Resonance Imaging in the Context of Active Surveillance |
| Q48107021 | Localized prostate cancer and robot-assisted laparoscopic radical prostatectomy: a retrospective, comparative study between pre- and post-operative Gleason scores |
| Q58562086 | MRI findings guiding selection of active surveillance for prostate cancer: a review of emerging evidence |
| Q90989090 | MRI in active surveillance: a critical review |
| Q50184941 | Management of prostate cancer: NYU Case of the Month, July 2017. |
| Q57049913 | PTEN status assessment in the Johns Hopkins active surveillance cohort |
| Q94550790 | Prediction of prostate cancer Gleason score upgrading from biopsy to radical prostatectomy using pre-biopsy multiparametric MRI PIRADS scoring system |
| Q88335236 | Prognostic Significance of a Negative Confirmatory Biopsy on Reclassification Among Men on Active Surveillance |
| Q89845717 | Prospective evaluation of fexapotide triflutate injection treatment of Grade Group 1 prostate cancer: 4-year results |
| Q47149516 | Prostate Cancer Imaging and Biomarkers Guiding Safe Selection of Active Surveillance |
| Q51733070 | Reduction of MRI-targeted biopsies in men with low-risk prostate cancer on active surveillance by stratifying to PI-RADS and PSA-density, with different thresholds for significant disease. |
| Q38924660 | Risk-stratification based on magnetic resonance imaging and prostate-specific antigen density may reduce unnecessary follow-up biopsy procedures in men on active surveillance for low-risk prostate cancer |
| Q38671172 | Role of prostate magnetic resonance imaging in active surveillance. |
| Q48527660 | Targeted Prostate Biopsy in the Era of Active Surveillance |
| Q39356191 | The Contemporary Role of Multiparametric Magnetic Resonance Imaging in Active Surveillance for Prostate Cancer. |
| Q48293477 | The role of whole-lesion apparent diffusion coefficient analysis for predicting outcomes of prostate cancer patients on active surveillance |
| Q46194986 | Value of Tracking Biopsy in Men Undergoing Active Surveillance of Prostate Cancer |
Search more.